Sri Suryo
Sri Suryo
Sri Suryo
ABSTRACT
The transportation effect of the Pneumatic Tube System (PTS) on platelet activity remains controversial. This study
aimed to analyze the effect of PTS in the platelet aggregation test in Dr. Cipto Mangunkusumo Hospital, Jakarta. This
cross-sectional study was carried out in the Clinical Pathology Laboratory of Dr. Cipto Mangunkusumo Hospital (RSUPNCM)
from March to April 2021. There were 50 subjects involved in this study, each of whom 6 sodium citrate blood tubes were
extracted. Three tubes were sent through PTS while the rest were transported manually. All tubes were then tested for
platelet count and platelet aggregation using ADP agonists of 1 μM, 5 μM, and 10 μM. There was a lower platelet count
(p=0.046) and platelet aggregation in ADP 1 μM (p=0.037), ADP 5 μM (p <0.001), and ADP 10 μM (p <0.001) at
PTS-transported samples. Eleven samples were interpreted distinctively as low platelet aggregation in PTS transportation
became normal in manual delivery. Cohen's Kappa value was 0.51 (p <0.001). A decreasing platelet count and platelet
aggregation in PTS samples indicated that acceleration and deceleration during transportation could lead to platelet
activation, thus resulting in a lower result after being added to an agonist. Cohen's Kappa test showed that manual
transportation could not be replaced with PTS for the platelet aggregation test. Platelet count and platelet aggregation were
found to be lower in PTS-transported samples. It was suggested to centralize specimen taking for platelet aggregation tests,
thus manual transportation can be conducted more efficiently.
were patients without fasting for at least 8 hours the remaining three tubes were sent via manual
before sampling, clotted, lysed, insufficient blood delivery and were then analyzed within 30-120
sample, patients who smoked within 30 minutes minutes.
before sampling, and patients whose platelet count First, Platelet Rich Plasma (PRP) was prepared by
was less than 100,000/μL in samples transported by centrifuging the blood at a speed of 1000 rpm or 100
manual delivery.2 Calculation of the sample size was g for 15 minutes and then the plasma obtained was
determined based on the regulation by Clinical and transferred to a cuvette of at least 1500 L, the platelet
Laboratory Standards Institute (CLSI) EP09-A3, which count was analyzed using a Sysmex XN-1000
required a minimum sample size of 40 to analyze the hematology analyzer. The PRP platelet count should
comparison between the two methods.3 The sample be 200,000-300,000/L; a platelet count of less than
size in this study was set at 50 samples. The accuracy 100,000/L will lead to difficult to determine an optical
test carried out was a within-run test 5 times in a row baseline. Furthermore, the remaining blood in the
from one normal subject on the same day. The basic citrate tube was centrifuged again at 2400 g for 20
data on the characteristics of the research subjects minutes and was then transferred to a 500 L cuvette
such as age and gender were taken from the as Platelet Poor Plasma (PPP).4
National Identity Card (KTP). Blinding was not Platelet aggregation test was carried out using a
implemented in this study because the type of data Chrono-Log 490 aggregator with the Turbidimetric
was objective data obtained from measurements method according to Born based on changes in light
following the research flow in Figure 1. transmission as shown in Figure 2. Before the
A platelet aggregation test was carried out to addition of agonists, PRP light transmission was low
analyze the function of platelets by using ADP because platelets were still homogeneously
agonists with concentrations of 1 M, 5 M, and 10 M. suspended. After the addition of an agonist, platelets
The test used a whole blood sample from a vein undergo primary aggregation, then the aggregate
which was collected in a 3 mL tube containing 0.109 releases endogenous ADP, which causes secondary
M Na citrate anticoagulant in 6 tubes with Na citrate: aggregation and precipitates, leading to the
blood equal to 1:9. Three tubes were sent via PTS and production of clear plasma and increased light
transmission as described in Figure 3. The biological
PPDS participants or employees of the RSCM Central Laboratory of the Department of Clinical
Pathology, FKUI-RSCM
Inclusion criteria :
o 20-60 years old
Willing to fill out informed consent
Yes No
Exclusion criteria :
Yes
o The patient did not fast Not included in the research
o Frozen, lysed, an insufficient blood sample
o The patient smoked 30 minutes before sampling
No
statistic test
Figure 3. (A) Illustration of PRP sample before the addition of agonist, low light transmittance. (B) Illustration of
PRP sample after addition of agonist, light transmittance increases. (C) PRP samples before and after
the addition of agonist
Data processing was carried out using the SPSS A total of 50 subjects who met the inclusion
version 25 program. The accuracy test was used to criteria were included in this study consisting of 12
determine the average value, standard deviation, (24%) males and 38 (76%) females with a median age
and Coefficient of Variation (CV). Numerical variables of 34 years. The description of the characteristics of
were tested for normality to determine the the subject can be seen in Table 2.
distribution of data using the Saphiro-Wilk test
Table 2. Characteristics of research subjects
because the number of samples was < 50. Numerical
data were presented in mean and standard deviation Characteristics n=50
if the data distribution was normal or median and the
Age 34 (26-57)
minimum maximum value if the data distribution
Gender
was not normal. If the data distribution is normal,
Male 12 (24%)
then the mean difference between the examination
Female 38 (76%)
results of the samples sent by PTS and manual
submissions can be assessed by paired T-test. If the
The mean platelet count and platelet aggregation
data distribution is not normal, then the difference
with ADP agonists 1, 5, and 10 M in samples
between the two means can be analyzed by the
transported via PTS and manual delivery can be seen
Wilcoxon test. The Kappa test was conducted to
in Table 3.
assess the suitability of the interpretation of platelet
The results of the Saphiro-Wilk test results
aggregation results between samples sent via PTS
showed that data of platelet count and platelet
and manual delivery.
This research has been approved by the Research aggregation with ADP 1, 5, and 10 M in samples
Ethics Committee of the Faculty of Medicine, transported by PTS and manual delivery were not
University of Indonesia/Cipto Mangunkusumo normal (p>0.05). The mean platelet count and
Hospital with the number KET-113/UN2.F1/ETIK/ platelet aggregation with ADP 1, 5, and 10 M were
PPM.00.02/2021. presented in the median form (min–max) and
followed by the Wilcoxon test. Wilcoxon test results
RESULTS AND DISCUSSIONS showed p < 0.05, which indicated that there was a
significant difference between the mean platelet
The results of the within-run platelet aggregation count and platelet aggregation results with ADP 1, 5,
accuracy test using ADP 1, 5, and 10 M agonists can and 10 M in samples transported by PTS and manual
be seen in Table 1. delivery.
Table 1. In-run accuracy test of platelet aggregation against ADP 1, 5, and 10 M in the clinical pathology
laboratory of RSUPNCM
Test ADP 1 µM (%) ADP 5 µM (%) ADP 10 µM (%)
1 0 32 70
2 0 22 61
3 0 28 78
4 0 45 71
5 0 29 71
Mean 0 31.2 70.2
SD 0 8.5 6.1
CV (%) 0 27.3 8.6
Table 3. Mean platelet count, and platelet aggregation results with ADP 1, 5, and 10 M in samples transported
by PTS and manual delivery
Transportation
Parameter Difference in Results p-value
PTS Manual
3
Platelet count (x 10 /μL) 230.5 (54–329) 242.5 (105–323) 7.5 (-87–159) 0.046
ADP 1 μM (%) 0 (0–11) 1 (0–12) 0 (-5–9) 0.037
ADP 5 μM (%) 15.5 (0–88) 25 (0–72) 6 (-24–43) <0.001
ADP 10 μM (%) 35 (0–84) 60 (1–88) 9.5 (-24–50) <0.001
Table 4. Interpretation of platelet aggregation results with ADP 1, 5, and 10 M in samples transported by PTS
and manual delivery
Interpretation of Platelet Transportation
Aggregation Results with ADP 1, 5,
and 10 µM PTS Manual
Low platelet aggregation 31 (62%) 20 (40%)
Normal platelet aggregation 19 (38%) 30 (60%)
High platelet aggregation 0 0
Table 5. The results of the Kappa suitability analysis of platelet aggregation in samples transported by PTS and
manual delivery
Platelet aggregation test results
Total Kappa p-value
with PTS
Low Normal High
Platelet Low 20 0 0 20 0.51 <0.001
aggregation test Normal 11 19 0 30
results with manual High 0 0 0 0
delivery transport Total 31 19 0 50